Stelara erosion
Guidance pace
Accelerated
Talc liability
Settled
Re-escalated
Dividend: streak secure
How the JNJ dividend is funded: revenue replacement refills a cash pool that the talc liability drains, with a failure branch squeezing the payout
Two levers reroute company cash flow and move the payout gauge toward the danger zone
Revenue mix
Innovative Medicine
Replacement growth
Darzalex + new launches
+ med-tech growth
Stelara erosion
biosimilar
share loss
+
−
erosion faster than guidance
Net revenue
replacement
erosion vs growth
Operating cash flow
pool / FCF reservoir
Dividend payout
funds 64-yr streak
payout in range
danger zone
Talc settlement
contingent cash drain
Cash squeeze
payout ratio toward
danger zone
1
2
3
4
5
6
teal = cash into the dividend
amber/coral = contingent tie-ups
red = failure branch